Possible antitumor activity of 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine (ECyd, TAS-106) against an established gemcitabine (dFdCyd)-resistant human pancreatic cancer cell line.
about
Antimetabolites and cancer: emerging data with a focus on antifolates.Recent advances in the treatment of peritoneal dissemination of gastrointestinal cancers by nucleoside antimetabolites.Attenuation of phosphorylation by deoxycytidine kinase is key to acquired gemcitabine resistance in a pancreatic cancer cell line: targeted proteomic and metabolomic analyses in PK9 cells.Disrupted plasma membrane localization of equilibrative nucleoside transporter 2 in the chemoresistance of human pancreatic cells to gemcitabine (dFdCyd).Combination of human tumor necrosis factor-alpha (hTNF-alpha) gene delivery with gemcitabine is effective in models of pancreatic cancer.Overcoming tumor cell chemoresistance using nanoparticles: lysosomes are beneficial for (stearoyl) gemcitabine-incorporated solid lipid nanoparticles.
P2860
Possible antitumor activity of 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine (ECyd, TAS-106) against an established gemcitabine (dFdCyd)-resistant human pancreatic cancer cell line.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Possible antitumor activity of ...... n pancreatic cancer cell line.
@en
type
label
Possible antitumor activity of ...... n pancreatic cancer cell line.
@en
prefLabel
Possible antitumor activity of ...... n pancreatic cancer cell line.
@en
P2093
P2860
P1433
P1476
Possible antitumor activity of ...... n pancreatic cancer cell line.
@en
P2093
Akio Fujioka
Akira Matsuda
Hiromi Kazuno
Kazuki Sakamoto
Masakazu Fukushima
Takuma Sasaki
P2860
P304
P356
10.1111/J.1349-7006.2005.00046.X
P577
2005-05-01T00:00:00Z